152 related articles for article (PubMed ID: 30608425)
1. The herbal drug, Bu-Zhong-Yi-Qi-Tang, for the treatment of atopic dermatitis: Protocol for a systematic review.
Jeong MK; Kim YE; Kim A; Jung J; Son MJ
Medicine (Baltimore); 2019 Jan; 98(1):e13938. PubMed ID: 30608425
[TBL] [Abstract][Full Text] [Related]
2. Herbal medicine (Bojungikki-tang) for allergic rhinitis: A protocol for a systematic review of controlled trials.
Lee JA; Jang S; Jun JH; Lee MS; Lee E; Kim N; Lee DH
Medicine (Baltimore); 2018 Jan; 97(3):e9551. PubMed ID: 29504976
[TBL] [Abstract][Full Text] [Related]
3. Okbyungpoongsan (Yupingfeng) for treating allergic rhinitis: A protocol for the systematic review of controlled trials.
Lee M; Kim Y; Lee JA
Medicine (Baltimore); 2018 Nov; 97(45):e13227. PubMed ID: 30407365
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunomodulatory evaluation and chemical profile elucidation of a classical traditional Chinese formula, Bu-Zhong-Yi-Qi-Tang.
Liu L; Hu L; Yao Z; Qin Z; Idehara M; Dai Y; Kiyohara H; Yamada H; Yao X
J Ethnopharmacol; 2019 Jan; 228():188-199. PubMed ID: 30195569
[TBL] [Abstract][Full Text] [Related]
5. Antiinflammatory effects of Bu-zhong-yi-qi-tang in patients with perennial allergic rhinitis.
Yang SH; Yu CL
J Ethnopharmacol; 2008 Jan; 115(1):104-9. PubMed ID: 17980528
[TBL] [Abstract][Full Text] [Related]
6. Immune-modulatory effects of bu-zhong-yi-qi-tang in ovalbumin-induced murine model of allergic asthma.
Yang SH; Kao TI; Chiang BL; Chen HY; Chen KH; Chen JL
PLoS One; 2015; 10(6):e0127636. PubMed ID: 26035827
[TBL] [Abstract][Full Text] [Related]
7. Effects of Bu-Zhong-Yi-Qi-Tang for the treatment of functional dyspepsia: a feasibility study protocol.
Kim J; Kim H; Kim KH
Integr Med Res; 2017 Sep; 6(3):317-324. PubMed ID: 28951846
[TBL] [Abstract][Full Text] [Related]
8. In vivo metabolic profiles of Bu-Zhong-Yi-Qi-Tang, a famous traditional Chinese medicine prescription, in rats by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
Hu L; Yao Z; Qin Z; Liu L; Song X; Dai Y; Kiyohara H; Yamada H; Yao X
J Pharm Biomed Anal; 2019 Jul; 171():81-98. PubMed ID: 30981193
[TBL] [Abstract][Full Text] [Related]
9. A screening strategy for bioactive components of Bu-Zhong-Yi-Qi-Tang regulating spleen-qi deficiency based on "endobiotics-targets-xenobiotics" association network.
Hu L; Chen J; Duan H; Zou Z; Qiu Y; Du J; Chen J; Yao X; Kiyohara H; Nagai T; Yao Z
J Ethnopharmacol; 2023 Oct; 314():116605. PubMed ID: 37178982
[TBL] [Abstract][Full Text] [Related]
10. Herbal medicine (Suoquan) for treating nocturnal enuresis: A protocol for a systematic review of randomized controlled trials.
Lee YB; Ah Lee J; Soobin Jang ; Lim Lee H
Medicine (Baltimore); 2018 Apr; 97(17):e0391. PubMed ID: 29702985
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
Son MJ; Kim MH; Kang M; Kim YE; Jung J; Choi I
Medicine (Baltimore); 2020 Jul; 99(28):e20675. PubMed ID: 32664064
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics.
Zheng XF; Tian JS; Liu P; Xing J; Qin XM
J Ethnopharmacol; 2014 Feb; 151(2):912-20. PubMed ID: 24333365
[TBL] [Abstract][Full Text] [Related]
13. Eunkyosan for treatment of the common cold: A protocol for the systematic review of controlled trials.
Lee H; Kang B; Choi JY; Park S; Lee MS; Lee JA
Medicine (Baltimore); 2018 May; 97(18):e0527. PubMed ID: 29718842
[TBL] [Abstract][Full Text] [Related]
14. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest.
Kao ST; Yeh CC; Hsieh CC; Yang MD; Lee MR; Liu HS; Lin JG
Life Sci; 2001 Aug; 69(13):1485-96. PubMed ID: 11554610
[TBL] [Abstract][Full Text] [Related]
15. Banxia Xiexin tang for gastro-oesophageal reflux disease: A protocol for a systematic review of controlled trials.
Kang B; Lee H; Choi Y; Jeon C; Lee JA
Medicine (Baltimore); 2018 Apr; 97(17):e0393. PubMed ID: 29702986
[TBL] [Abstract][Full Text] [Related]
16. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhoea: protocol for a systematic review of randomised controlled trials.
Jo J; Leem J; Lee JM; Park KS
BMJ Open; 2017 Jun; 7(6):e015056. PubMed ID: 28619773
[TBL] [Abstract][Full Text] [Related]
17. Hochu-ekki-to suppresses development of dermatitis and elevation of serum IgE level in NC/Nga mice.
Kobayashi H; Mizuno N; Kutsuna H; Teramae H; Ueoku S; Onoyama J; Yamanaka K; Fujita N; Ishii M
Drugs Exp Clin Res; 2003; 29(2):81-4. PubMed ID: 12951838
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells.
Kao ST; Yang SL; Hsieh CC; Yang MD; Wang TF; Lin JG
Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):711-20. PubMed ID: 11105783
[TBL] [Abstract][Full Text] [Related]
19. The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine.
Kim SH; Lee SE; Oh H; Kim SR; Yee ST; Yu YB; Byun MW; Jo SK
Am J Chin Med; 2002; 30(1):127-37. PubMed ID: 12067087
[TBL] [Abstract][Full Text] [Related]
20. Integrating network pharmacology and experimental verification to decipher the immunomodulatory effect of Bu-Zhong-Yi-Qi-Tang against poly (I:C)-induced pulmonary inflammation.
Hu L; Yamamoto M; Chen J; Duan H; Du J; He L; Shi D; Yao X; Nagai T; Kiyohara H; Yao Z
Front Pharmacol; 2022; 13():1015486. PubMed ID: 36304166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
